No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
294 |
4. Check minimum number of eventsNone |
294 |
5. Include endpointsNone |
294 |
6. Filter based on genotype QC (FinnGen only) |
287 |
Control definitions (FinnGen only)
- Control exclude
- AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Unspecified parasitic disease
based on the number of shared cases.
Similar with more cases:
- Pediculosis, acariasis and other infestations
- Pediculosis, acariasis and other infestations
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3445 | 1243 | 2130 |
| Only index persons | 2322 | 862 | 1460 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.04 | 0.06 |
| Only index persons | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 32.23 | 33.08 | 31.02 |
| Only index persons | 26.02 | 24.89 | 26.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 287 | 130 | 157 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 27.46 | 21.41 | 32.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 294
- Matched controls
- 2940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
13609
ICD-8 Finland
Other and unspecified infective and parasitic diseases, Morbus infectiosus sive parasitarius NUD
+∞
114.2
102
*
13603
ICD-8 Finland
Other and unspecified infective and parasitic diseases, Morbus Reiter, syndroma urethro-oculo-articularis
+∞
97.4
88
*
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
52.7
49
*
13608
ICD-8 Finland
Other and unspecified infective and parasitic diseases
+∞
32.9
31
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.4
22.9
68
188
M02.3
ICD-10 Finland
Reiter disease
168.6
15.6
16
*
L01BA01
ATC
methotrexate; systemic
5.9
11.3
21
38
A07EC01
ATC
sulfasalazine; oral, rectal
3.5
10.0
37
117
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
103.2
9.5
10
*
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
38.0
9.1
11
*
L04AA01
ATC
[U] ciclosporin
15.6
7.8
12
8
M45
ICD-10 Finland
Ankylosing spondylitis
6.8
7.5
18
28
1363A
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Pneumocystosis
+∞
7.3
7
*
Z2221
NOMESCO Finland
Medical doctor
2.1
7.3
89
505
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
7.1
6.6
15
22
B89
ICD-10 Finland
Unspecified parasitic disease
+∞
6.3
6
*
M05BA04
ATC
alendronic acid; oral
3.0
6.2
28
100
Z3226
NOMESCO Finland
Physiotherapist
2.2
6.0
60
313
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.0
141
985
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
171
1153
2.15
9.35
9.7
6.1
28.07
27.15
%
0.46
165
1093
167
1139
2.08
8.59
9.4
5.8
56.47
57.97
%
0.85
162
1082
181
1370
1.84
5.88
11.9
9.6
4.19
4.20
e9/l
0.02
160
1210
33
138
2.57
5.45
1.9
1.6
—
—
—
0
0
152
1126
1.72
5.00
8.7
6.8
1.21
1.21
mmol/l
0.00
133
966
65
391
1.85
4.29
2.8
2.7
3.74
1.59
e6/l
0.53
40
218
26
112
2.45
4.05
1.7
1.8
1.54
1.64
g/l
0.28
21
97
67
416
1.79
3.98
2.7
2.5
2.08
1.10
e6/l
0.25
43
240
124
910
1.63
3.96
3.0
2.2
77.96
76.24
nmol/l
0.25
116
815
138
1040
1.62
3.95
6.9
5.9
1.21
1.21
mmol/l
0.16
130
960
96
667
1.65
3.78
3.8
2.9
0.46
0.53
e6/l
0.09
78
502
18
67
2.80
3.73
1.6
1.2
—
—
—
0
0
116
858
1.58
3.49
3.8
3.0
—
—
—
0
0
107
782
1.58
3.36
4.5
3.1
33.58
32.54
u/l
0.09
102
748
91
641
1.61
3.33
3.2
2.9
362.45
7868.20
umol/l
3.06
84
557
59
373
1.73
3.26
2.2
1.8
—
—
—
0
0
80
558
1.60
3.02
3.1
2.3
—
—
—
0
0
67
451
1.63
2.92
4.0
3.4
400.59
140.32
ng/l
0.51
56
340
173
1437
1.50
2.86
3.0
3.0
—
—
—
0
0
31
168
1.94
2.80
6.4
4.1
134.65
82.11
ng/l
1.25
26
151
49
309
1.70
2.73
7.4
6.4
104.27
104.04
mmol/l
0.13
49
309
45
278
1.73
2.70
5.4
4.4
207.82
243.62
u/l
2.93
45
265
9
24
3.83
2.69
1.1
1.1
—
—
—
0
0
164
1358
1.47
2.68
6.6
4.8
6.89
6.70
mmol/l
0.44
157
1271
120
936
1.48
2.66
2.3
2.0
89.93
94.64
pmol/l
0.50
58
509
61
415
1.59
2.53
1.8
1.7
1141.22
1173.06
nmol/l
0.08
49
324
35
206
1.79
2.47
6.4
6.7
1.13
1.32
mmol/l
0.99
35
200
71
505
1.54
2.43
2.1
1.7
1.21
1.21
mg/l
0.00
56
393
5
8
6.33
2.38
1.2
1.1
—
—
—
0
0
16
72
2.29
2.32
4.5
2.8
1.71
1.51
mg/l
0.36
16
66
11
43
2.62
2.10
3.5
3.2
3.18
4.64
e9/l
1.56
11
43
10
38
2.69
2.02
1.3
1.9
—
—
—
0
0
10
38
2.69
2.02
1.6
3.2
—
1265.40
u/ml
—
0
5
9
32
2.87
2.02
1.6
1.4
—
—
—
0
0
11
45
2.50
1.95
3.5
3.6
50.18
59.20
%
1.15
11
45
9
33
2.78
1.95
1.7
1.4
—
—
—
0
0
9
33
2.78
1.95
1.7
1.4
—
—
—
0
0
9
33
2.78
1.95
1.7
1.4
—
—
—
0
0
74
556
1.44
1.91
2.1
1.6
19.39
20.92
nmol/l
0.36
64
467
9
34
2.70
1.88
1.7
1.4
—
—
—
0
0
120
984
1.37
1.87
4.5
2.7
212.41
150.55
ug/l
0.78
113
920
40
266
1.58
1.83
2.4
1.7
—
—
—
0
0
205
1833
1.39
1.83
11.3
7.8
75.88
77.31
u/l
0.19
195
1729
5
12
4.22
1.83
1.0
1.3
—
—
—
0
0
94
746
1.38
1.77
4.5
3.8
26.46
8.89
mg/mmol
1.16
68
466
8
30
2.71
1.73
4.3
3.4
—
—
—
0
0
135
1138
1.34
1.73
5.6
4.8
0.00
0.00
estimate
-0.00
31
231
5
13
3.89
1.72
1.4
1.1
—
—
—
0
0
28
174
1.67
1.68
8.9
2.9
4.85
4.45
kpa
0.38
28
167
13
62
2.15
1.68
1.7
1.3
—
—
—
0
0
10
41
2.49
1.66
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
63
2.11
1.62
2.5
2.3
0.31
0.30
u/ml
—
7
37
39
266
1.54
1.62
2.5
1.8
—
—
—
0
0
130
1101
1.32
1.57
29.1
14.3
1.28
1.30
inr
0.07
39
327
35
235
1.56
1.56
3.0
2.1
341.29
372.94
nmol/l
0.46
35
216
8
33
2.46
1.55
1.5
1.4
—
—
—
0
0
134
1145
1.31
1.51
4.0
3.5
0.00
0.00
estimate
0.50
32
247
35
237
1.54
1.51
2.7
3.6
—
—
—
0
0
252
2363
1.47
1.49
21.6
14.3
23.56
23.51
mg/l
0.01
210
1871
31
205
1.57
1.48
13.9
7.7
10.69
10.16
mmol/l
0.18
31
198
32
215
1.55
1.43
11.1
3.7
5.89
5.65
kpa
0.93
32
209
257
2427
1.47
1.38
22.3
15.9
139.33
139.73
mmol/l
1.41
246
2368
5
17
2.97
1.36
1.8
1.6
12.80
14.00
u/l
—
5
17
134
1158
1.29
1.35
4.0
3.5
0.00
0.00
estimate
-0.00
28
222
118
1004
1.29
1.33
6.9
4.7
35.05
35.58
g/l
0.46
106
953
193
1750
1.30
1.32
3.9
3.8
14.84
14.77
pmol/l
0.15
177
1577
241
2255
1.38
1.32
4.2
4.0
1.40
1.28
mmol/l
1.15
226
2074
36
257
1.46
1.23
5.7
7.2
0.05
1.12
mmol/l
1.10
31
214
12
64
1.91
1.20
2.1
1.5
—
—
—
0
0
256
2431
1.41
1.17
22.7
16.1
4.01
3.99
mmol/l
0.60
245
2372
38
277
1.43
1.17
5.4
3.2
6.43
7.59
umol/l
0.36
32
241
235
2203
1.33
1.17
6.3
5.8
39.88
40.05
mmol/mol
0.09
217
2065
247
2333
1.37
1.16
4.8
4.5
1.40
1.44
mmol/l
0.86
231
2158
241
2268
1.35
1.16
19.3
13.1
78.68
81.12
ml/min/173m2
0.87
201
1890
16
95
1.72
1.16
1.9
2.5
—
—
—
0
0
22
143
1.58
1.15
1.3
1.4
—
—
—
0
0
12
65
1.88
1.15
1.8
1.4
310.83
295.07
ug/g
—
6
33
10
51
1.99
1.12
1.2
1.3
—
—
—
0
0
10
51
1.99
1.12
1.2
1.3
—
—
—
0
0
11
59
1.90
1.09
1.2
1.2
—
—
—
0
0
229
2148
1.30
1.07
5.1
4.5
1.80
1.93
mu/l
1.06
217
1955
35
256
1.42
1.07
5.9
7.1
5.20
5.11
kpa
0.18
35
246
83
693
1.28
1.06
3.3
3.1
1283.39
1223.28
ng/l
0.07
73
591
9
46
1.99
1.04
1.6
1.5
—
—
—
0
0
9
46
1.99
1.04
1.2
1.3
1.56
25.00
e6/l
—
9
33
9
46
1.99
1.04
1.4
1.1
93.29
38.59
u/l
—
9
40
9
46
1.99
1.04
1.6
1.4
164.00
258.20
e6/l
—
9
35
11
60
1.87
1.04
1.6
1.9
—
—
—
0
0
5
22
2.29
1.04
1.0
1.2
—
—
—
0
0
140
1246
1.24
1.02
8.9
6.7
9.66
11.56
umol/l
3.69
133
1186
79
660
1.27
1.00
1.8
1.7
1.57
1.39
mmol/l
0.77
67
555
11
61
1.83
1.00
3.2
1.5
—
—
—
0
0
23
157
1.50
0.99
2.0
1.4
—
—
—
0
0
124
1095
1.23
0.96
3.9
2.5
—
—
—
0
0
6
27
2.25
0.94
1.0
1.6
—
—
—
0
0
27
195
1.42
0.90
3.0
2.8
51.89
67.14
ml/min/173m2
—
9
83
34
256
1.37
0.90
6.0
7.1
11.49
12.20
kpa
0.65
34
248
13
79
1.68
0.89
1.8
1.7
—
—
—
0
0
10
56
1.81
0.89
1.3
1.3
—
—
—
0
0
6
30
2.02
0.87
2.8
2.5
—
—
—
0
0
246
2348
1.29
0.86
4.8
4.5
4.51
4.61
mmol/l
0.73
232
2193
262
2522
1.36
0.86
14.8
10.6
35.71
26.75
u/l
0.49
256
2446
242
2306
1.28
0.85
4.7
4.6
6.15
5.96
mmol/l
0.82
218
2122
250
2392
1.30
0.85
5.4
5.0
2.69
2.74
mmol/l
0.35
236
2218
11
66
1.69
0.80
1.2
1.3
—
—
—
0
0
21
287
0.71
0.76
7.9
7.1
—
—
—
0
0
5
24
2.10
0.75
1.6
1.1
—
—
—
0
0
51
420
1.26
0.74
4.0
2.9
2.43
2.45
mmol/l
0.42
45
375
269
2611
1.36
0.72
29.8
21.0
39.79
40.38
%
0.84
260
2471
269
2613
1.35
0.70
29.7
20.9
4.41
4.51
e12/l
2.41
258
2551
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
5
27
1.87
0.68
1.4
1.2
—
—
—
0
0
5
27
1.87
0.68
1.2
1.6
24.25
16.00
ug/l
—
5
27
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
269
2614
1.34
0.68
29.8
21.0
133.41
136.35
g/l
2.31
264
2579
25
325
0.75
0.67
1.5
1.4
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
11
70
1.59
0.66
2.3
2.1
517.83
111.83
ug/min
—
6
39
86
759
1.19
0.64
3.8
3.3
2.33
2.34
mmol/l
0.46
76
681
24
182
1.35
0.63
1.9
1.6
—
—
—
0
0
16
113
1.44
0.62
5.1
2.6
0.61
0.66
%
0.33
16
113
13
88
1.50
0.61
1.9
1.9
—
—
—
0
0
190
1793
1.17
0.61
6.2
4.0
15.10
11.94
mm/h
1.64
184
1661
11
72
1.55
0.60
1.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
3.4
—
65.53
—
0
22
268
2611
1.30
0.59
29.7
20.9
247.49
245.42
e9/l
0.20
258
2555
11
73
1.53
0.57
1.0
1.2
—
—
—
0
0
60
520
1.19
0.55
1.5
1.2
2.01
1.93
u/ml
0.02
14
162
26
205
1.29
0.54
2.0
1.7
—
—
—
0
0
10
66
1.53
0.53
1.7
1.8
—
—
—
0
0
46
392
1.21
0.51
1.3
1.3
7.29
14.29
u/ml
0.48
14
155
55
478
1.19
0.50
1.7
1.7
380.84
434.76
pmol/l
1.07
49
395
7
106
0.65
0.49
2.3
2.2
147.29
35.42
u/ml
—
7
101
16
119
1.36
0.49
5.1
2.6
0.94
1.19
%
0.70
16
119
7
48
1.47
0.47
1.7
1.7
—
—
—
0
0
7
48
1.47
0.47
1.7
1.7
—
—
—
0
0
20
156
1.30
0.46
1.4
1.2
92.67
157.08
iu/ml
—
6
71
47
406
1.19
0.46
1.3
1.3
26.23
32.96
iu/ml
0.28
18
142
5
31
1.62
0.43
6.0
3.0
2.80
4.55
nmol/l
—
5
31
99
912
1.13
0.42
4.5
3.7
73.29
44.95
ng/l
0.51
69
648
5
33
1.52
0.41
2.0
1.5
—
—
—
0
0
5
33
1.52
0.41
2.0
1.5
—
—
—
0
0
5
33
1.52
0.41
1.6
3.1
—
29.73
—
0
10
11
83
1.34
0.32
1.6
2.6
—
—
—
0
0
13
102
1.29
0.30
1.2
1.7
—
—
—
0
0
8
63
1.28
0.28
1.6
1.3
—
—
—
0
0
8
63
1.28
0.28
1.5
1.2
—
—
—
0
0
20
234
0.84
0.26
1.3
1.8
—
—
—
0
0
12
96
1.26
0.25
1.8
1.3
29.42
30.77
iu/l
0.04
12
82
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
64
599
1.09
0.20
2.6
3.1
0.60
0.81
ug/l
1.83
50
404
6
48
1.26
0.20
1.2
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.17
—
0
9
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
12
99
1.22
0.20
2.0
2.0
26.71
5.61
ug/l
0.35
12
90
105
1005
1.07
0.19
4.0
5.0
1.87
2.80
ug/l
1.45
92
905
7
58
1.21
0.18
1.4
1.5
—
—
—
0
0
8
68
1.18
0.16
1.6
1.6
—
—
—
0
0
165
1611
1.06
0.15
4.2
3.1
55.38
49.24
u/l
0.46
151
1523
13
114
1.15
0.12
1.0
1.3
—
—
—
0
0
17
153
1.12
0.11
3.9
3.8
2.57
1.59
mmol/l
0.64
12
119
83
806
1.04
0.09
3.6
4.4
22.86
21.65
%
0.23
39
399
65
629
1.04
0.08
4.4
3.7
0.00
0.01
estimate
0.50
29
220
7
67
1.05
0.08
1.7
1.6
—
—
—
0
0
9
86
1.05
0.07
1.9
2.9
—
—
—
0
0
31
296
1.05
0.06
4.8
4.8
30.80
31.39
%
0.11
25
205
77
756
1.03
0.04
3.4
2.4
60.15
62.93
u/l
0.15
68
710
90
910
0.98
0.02
4.6
3.6
—
—
—
0
0
14
138
1.02
0.00
4.0
3.2
4.26
4.57
pmol/l
0.45
14
126
12
117
1.03
0.00
1.1
1.0
—
—
—
0
0
39
387
1.01
0.00
1.5
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
131.78
—
0
9
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
42.44
—
0
9
6
59
1.02
-0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
-0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
82
0.97
-0.00
1.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
50
1.00
-0.00
2.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
20.93
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint AB1_PARASITIC_NOS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_PARASITIC_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_PARASITIC_NOS – Unspecified parasitic disease
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data